开发并验证基于超声的影像组学模型预测高危子宫内膜癌
多中心回顾性观察研究,训练集396例、外部验证集102例,基于术前超声图像构建影像组学、临床-超声及混合模型,预测高危与低危子宫内膜癌。验证集中高危预测临床-超声模型AUC 0.90,影像组学模型AUC 0.80;低危预测临床-超声与混合模型AUC均为0.85。影像组学特征加入临床-超声模型未见性能明显提升。
要点
- 验证集中高危子宫内膜癌预测:临床-超声模型AUC 0.90,优于影像组学模型AUC 0.80和混合模型AUC 0.88。
- 低危子宫内膜癌预测:临床-超声与混合模型AUC均为0.85,影像组学模型AUC 0.71。
- 影像组学特征加入临床-超声模型后性能未见明显提升,作者认为需进一步疗效与效果研究验证。
核心结论
- 影像组学似乎有一定能力区分低危子宫内膜癌与其他子宫内膜癌,区分高危子宫内膜癌与其他子宫内膜癌的能力更好;但将影像组学特征加入临床-超声模型未带来性能明显提升,仍需其他疗效研究和进一步效果研究验证模型性能。
研究设计与样本
- 多中心、回顾性、观察性研究;两家参与中心2016—2019年连续纳入经组织学确诊、由经验丰富检查者行术前超声的子宫内膜癌患者;中心1(罗马)为训练集396例,中心2(米兰)为外部验证集102例;参考标准为ESMO-ESGO-ESTRO 2016高危定义。
诊断标准与关键数值
- 验证集高危预测:影像组学模型AUC 0.80、敏感度58.7%、特异度85.7%(最佳风险截断值0.41);临床-超声模型AUC 0.90、敏感度80.4%、特异度83.9%(最佳截断值0.32);混合模型AUC 0.88、敏感度67.3%、特异度91.0%(最佳截断值0.42)。验证集低危预测:影像组学模型AUC 0.71、敏感度65.0%、特异度64.5%(最佳截断值0.38);临床-超声模型AUC 0.85、敏感度70.0%、特异度80.6%(最佳截断值0.46);混合模型AUC 0.85、敏感度87.5%、特异度72.5%(最佳截断值0.36)。
临床应用与阅片要点
- 作者认为影像组学似乎有一定能力区分低危与高危子宫内膜癌,但将影像组学特征加入临床-超声模型未带来性能明显提升,并指出仍需其他疗效研究和进一步效果研究验证模型性能。
局限性
- 原文结论指出其他疗效研究和进一步效果研究仍需开展以验证模型性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The primary aim of this study was to develop and validate radiomics models, applied to ultrasound images, capable of differentiating from other cancers high-risk endometrial cancer, as defined jointly by the European Society for Medical Oncology, European Society of Gynaecological Oncology and European Society for Radiotherapy & Oncology (ESMO-ESGO-ESTRO) in 2016. The secondary aim was to develop and validate radiomics models for differentiating low-risk endometrial cancer from other endometrial cancers.
METHODS: This was a multicenter, retrospective, observational study. From two participating centers, we identified consecutive patients with histologically confirmed diagnosis of endometrial cancer who had undergone preoperative ultrasound examination by an experienced examiner between 2016 and 2019. Patients recruited in Center 1 (Rome) were included as the training set and patients enrolled in Center 2 (Milan) formed the external validation set. Radiomics analysis (extraction of a high number of quantitative features from medical images) was applied to the ultrasound images. Clinical (including preoperative biopsy), ultrasound and radiomics features that were statistically significantly different in the high-risk group vs the other groups and in the low-risk group vs the other groups on univariate analysis in the training set were considered for multivariate analysis and for developing ultrasound-based machine-learning risk-prediction models. For discriminating between the high-risk group and the other groups, a random forest model from the radiomics features (radiomics model), a binary logistic regression model from clinical and ultrasound features (clinical-ultrasound model) and another binary logistic regression model from clinical, ultrasound and previously selected radiomics features (mixed model) were created. Similar models were created for discriminating between the low-risk group and the other groups. The models developed in the training set were tested in the validation set. The performance of the models in discriminating between the high-risk group and the other groups, and between the low-risk group and the other risk groups for both validation and training sets was compared.
RESULTS: The training set comprised 396 patients and the validation set 102 patients. In the validation set, for predicting high-risk endometrial cancer, the radiomics model had an area under the receiver-operating-characteristics curve (AUC) of 0.80, sensitivity of 58.7% and specificity of 85.7% (using the optimal risk cut-off of 0.41); the clinical-ultrasound model had an AUC of 0.90, sensitivity of 80.4% and specificity of 83.9% (using the optimal cut-off of 0.32); and the mixed model had an AUC of 0.88, sensitivity of 67.3% and specificity of 91.0% (using the optimal cut-off of 0.42). For the prediction of low-risk endometrial cancer, the radiomics model had an AUC of 0.71, sensitivity of 65.0% and specificity of 64.5% (using the optimal cut-off of 0.38); the clinical-ultrasound model had an AUC of 0.85, sensitivity of 70.0% and specificity of 80.6% (using the optimal cut-off of 0.46); and the mixed model had an AUC of 0.85, sensitivity of 87.5% and specificity of 72.5% (using the optimal cut-off of 0.36).
CONCLUSIONS: Radiomics seems to have some ability to discriminate between low-risk endometrial cancer and other endometrial cancers and better ability to discriminate between high-risk endometrial cancer and other endometrial cancers. However, the addition of radiomics features to the clinical-ultrasound models did not result in any notable increase in performance. Other efficacy studies and further effectiveness studies are needed to validate the performance of the models. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Moro F, Albanese M, Boldrini L, et al. Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer. Ultrasound Obstet Gynecol. 2022. PMID: 34714568. doi:10.1002/uog.24805
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。